ARYA SCIENCES ACQU CORP IV's ticker is ARYD and the CUSIP is G31659108. A total of 20 filers reported holding ARYA SCIENCES ACQU CORP IV in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,687,408 | +1.9% | 266,080 | 0.0% | 0.04% | -2.7% |
| Q3 2022 | $2,637,000 | +13.5% | 266,080 | +12.3% | 0.04% | +2.8% |
| Q2 2022 | $2,324,000 | +51.2% | 236,880 | +51.0% | 0.04% | +44.0% |
| Q1 2022 | $1,537,000 | -1.2% | 156,880 | 0.0% | 0.02% | +13.6% |
| Q4 2021 | $1,555,000 | -2.4% | 156,880 | -1.0% | 0.02% | -15.4% |
| Q3 2021 | $1,593,000 | -6.2% | 158,479 | 0.0% | 0.03% | -18.8% |
| Q2 2021 | $1,699,000 | +536.3% | 158,479 | +521.0% | 0.03% | +433.3% |
| Q1 2021 | $267,000 | – | 25,522 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 700,000 | $7,504,000 | 2.69% |
| Q Global Advisors, LLC | 86,730 | $930,000 | 0.65% |
| HealthCor Management, L.P. | 1,238,881 | $13,281,000 | 0.53% |
| Soleus Capital Management, L.P. | 300,000 | $3,216,000 | 0.50% |
| Bain Capital Life Sciences Investors, LLC | 700,000 | $7,504,000 | 0.49% |
| Union Square Park Capital Management, LLC | 100,500 | $1,077,000 | 0.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $5,360,000 | 0.36% |
| Consonance Capital Management LP | 250,000 | $2,680,000 | 0.32% |
| Altium Capital Management LP | 100,000 | $1,072,000 | 0.25% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,000,000 | $10,720,000 | 0.23% |